ARS Pharmaceuticals IncNASDAQ:SPRY
- LAST PRICE10.9800
- TODAY'S CHANGE (%)-0.2100 (-1.8767%)
- Bid / Lots10.5000/ 1
- Ask / Lots11.0600/ 6
- Open / Previous Close11.2500 / 11.1900
- Day Range
- 52 Week Range
- Volume593,972
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SPRY |
|---|---|---|
| 09:32 ET | 9760 | 11.24 |
| 09:34 ET | 2344 | 11.11 |
| 09:36 ET | 2777 | 11.13 |
| 09:38 ET | 9125 | 10.99 |
| 09:39 ET | 1312 | 11.035 |
| 09:41 ET | 2844 | 11.07 |
| 09:43 ET | 3300 | 11.06 |
| 09:45 ET | 2490 | 11.18 |
| 09:48 ET | 1750 | 11.17 |
| 09:50 ET | 4233 | 11.11 |
| 09:52 ET | 3100 | 11.12 |
| 09:54 ET | 12219 | 11.1075 |
| 09:56 ET | 2091 | 11.1 |
| 09:57 ET | 2126 | 11.08 |
| 09:59 ET | 1610 | 11.06 |
| 10:01 ET | 20097 | 11.1 |
| 10:03 ET | 1650 | 11.13 |
| 10:06 ET | 3900 | 11.1 |
| 10:08 ET | 1320 | 11.0501 |
| 10:10 ET | 1525 | 11.01 |
| 10:12 ET | 400 | 11.06 |
| 10:14 ET | 1468 | 10.99 |
| 10:15 ET | 1067 | 10.94 |
| 10:17 ET | 7813 | 10.96 |
| 10:19 ET | 681 | 10.97 |
| 10:21 ET | 582 | 10.9724 |
| 10:24 ET | 1300 | 10.985 |
| 10:26 ET | 1130 | 10.99 |
| 10:28 ET | 9440 | 11.05 |
| 10:30 ET | 4118 | 11.0802 |
| 10:32 ET | 1623 | 11.07 |
| 10:33 ET | 1377 | 11.065 |
| 10:35 ET | 100 | 11.065 |
| 10:37 ET | 1400 | 11.08 |
| 10:39 ET | 100 | 11.09 |
| 10:44 ET | 700 | 11.18 |
| 10:46 ET | 667 | 11.1603 |
| 10:48 ET | 3187 | 11.17 |
| 10:50 ET | 200 | 11.15 |
| 10:51 ET | 200 | 11.12 |
| 10:53 ET | 520 | 11.1 |
| 10:57 ET | 100 | 11.09 |
| 11:00 ET | 500 | 11.12 |
| 11:02 ET | 600 | 11.1 |
| 11:04 ET | 3572 | 11.04 |
| 11:06 ET | 100 | 11.02 |
| 11:09 ET | 100 | 11.03 |
| 11:11 ET | 200 | 11.05 |
| 11:13 ET | 900 | 11.02 |
| 11:15 ET | 4430 | 10.99 |
| 11:18 ET | 571 | 10.97 |
| 11:20 ET | 622 | 10.98 |
| 11:22 ET | 200 | 10.97 |
| 11:24 ET | 862 | 10.99 |
| 11:26 ET | 5350 | 11.01 |
| 11:29 ET | 800 | 11 |
| 11:31 ET | 991 | 11 |
| 11:33 ET | 609 | 11 |
| 11:36 ET | 200 | 10.98 |
| 11:38 ET | 600 | 11 |
| 11:40 ET | 400 | 11 |
| 11:42 ET | 300 | 10.97 |
| 11:44 ET | 100 | 10.98 |
| 11:45 ET | 100 | 10.99 |
| 11:47 ET | 700 | 11 |
| 11:51 ET | 600 | 11.02 |
| 11:54 ET | 200 | 11.01 |
| 11:56 ET | 1541 | 10.97 |
| 11:58 ET | 200 | 10.99 |
| 12:00 ET | 450 | 10.99 |
| 12:02 ET | 400 | 10.98 |
| 12:03 ET | 400 | 11 |
| 12:05 ET | 100 | 11 |
| 12:07 ET | 100 | 10.99 |
| 12:09 ET | 705 | 10.999 |
| 12:12 ET | 800 | 11 |
| 12:18 ET | 531 | 11 |
| 12:23 ET | 900 | 10.99 |
| 12:25 ET | 100 | 10.99 |
| 12:27 ET | 100 | 11.01 |
| 12:30 ET | 1309 | 10.99 |
| 12:32 ET | 100 | 10.97 |
| 12:34 ET | 455 | 10.972 |
| 12:36 ET | 200 | 10.96 |
| 12:38 ET | 400 | 10.96 |
| 12:41 ET | 100 | 10.97 |
| 12:43 ET | 100 | 10.97 |
| 12:45 ET | 1154 | 10.98 |
| 12:48 ET | 2100 | 10.96 |
| 12:52 ET | 500 | 10.94 |
| 12:56 ET | 2990 | 11.01 |
| 12:57 ET | 3184 | 11.02 |
| 12:59 ET | 2200 | 11.05 |
| 01:01 ET | 4623 | 11.1 |
| 01:06 ET | 2545 | 11.15 |
| 01:08 ET | 300 | 11.14 |
| 01:10 ET | 300 | 11.1001 |
| 01:15 ET | 600 | 11.1 |
| 01:19 ET | 241 | 11.09 |
| 01:21 ET | 26175 | 11.04 |
| 01:24 ET | 200 | 11.025 |
| 01:26 ET | 100 | 11.02 |
| 01:28 ET | 1615 | 11.05 |
| 01:30 ET | 300 | 11.05 |
| 01:32 ET | 617 | 11.03 |
| 01:33 ET | 200 | 11.03 |
| 01:35 ET | 1300 | 11.02 |
| 01:37 ET | 385 | 11.01 |
| 01:42 ET | 7562 | 11.02 |
| 01:44 ET | 300 | 11.025 |
| 01:46 ET | 600 | 11.05 |
| 01:48 ET | 500 | 11.05 |
| 01:50 ET | 100 | 11.05 |
| 01:51 ET | 700 | 11.049 |
| 01:53 ET | 905 | 11.05 |
| 01:55 ET | 400 | 11.05 |
| 01:57 ET | 700 | 11.05 |
| 02:00 ET | 850 | 11.035 |
| 02:02 ET | 600 | 11.04 |
| 02:04 ET | 400 | 11.04 |
| 02:06 ET | 300 | 11.05 |
| 02:08 ET | 100 | 11.04 |
| 02:09 ET | 500 | 11.03 |
| 02:11 ET | 200 | 11.05 |
| 02:13 ET | 100 | 11.05 |
| 02:15 ET | 600 | 11.05 |
| 02:18 ET | 100 | 11.05 |
| 02:20 ET | 1300 | 11.03 |
| 02:22 ET | 300 | 11.03 |
| 02:26 ET | 200 | 11.03 |
| 02:27 ET | 500 | 11.05 |
| 02:31 ET | 1500 | 11.03 |
| 02:33 ET | 200 | 11.01 |
| 02:42 ET | 568 | 11.02 |
| 02:44 ET | 2710 | 11.035 |
| 02:47 ET | 3222 | 11.03 |
| 02:51 ET | 100 | 11.02 |
| 02:54 ET | 5100 | 11.04 |
| 02:56 ET | 1300 | 11.03 |
| 02:58 ET | 10100 | 10.985 |
| 03:00 ET | 500 | 10.97 |
| 03:02 ET | 957 | 10.95 |
| 03:03 ET | 300 | 10.96 |
| 03:05 ET | 1400 | 10.95 |
| 03:07 ET | 427 | 10.955 |
| 03:09 ET | 2203 | 11.0001 |
| 03:12 ET | 100 | 11.01 |
| 03:14 ET | 4649 | 11 |
| 03:16 ET | 4900 | 10.98 |
| 03:18 ET | 1118 | 11 |
| 03:20 ET | 1325 | 11 |
| 03:21 ET | 400 | 11 |
| 03:23 ET | 2031 | 10.98 |
| 03:25 ET | 756 | 10.99 |
| 03:27 ET | 899 | 10.99 |
| 03:30 ET | 441 | 10.99 |
| 03:32 ET | 7401 | 10.985 |
| 03:34 ET | 1300 | 10.97 |
| 03:36 ET | 519 | 11.009 |
| 03:38 ET | 300 | 11.009 |
| 03:39 ET | 1500 | 11.02 |
| 03:41 ET | 1658 | 11.02 |
| 03:43 ET | 4433 | 11.01 |
| 03:45 ET | 2117 | 10.99 |
| 03:48 ET | 2118 | 11 |
| 03:50 ET | 3111 | 11 |
| 03:52 ET | 24801 | 11 |
| 03:54 ET | 7743 | 10.95 |
| 03:56 ET | 6144 | 10.955 |
| 03:57 ET | 15564 | 10.975 |
| 03:59 ET | 95284 | 10.98 |
Today
Yesterday
ARS Pharmaceuticals Inc Investigated By The Schall Law Firm And Impacted Investors Urged To Engage In Dialogue, from 4:02PM ET on Thursday Jul 25, 2024 by Dow Jones
4:02PM ET on Thursday Jul 25, 2024 by Dow JonesDJ ARS Pharmaceuticals Initiated at Outperform by Raymond James, from 1:09PM ET on Thursday Jul 25, 2024 by Dow Jones
1:09PM ET on Thursday Jul 25, 2024 by Dow Jones
Jul 24, 2024
ARS Pharmaceuticals Inc Investigated By The Schall Law Firm And Impacted Investors Urged To Engage In Dialogue, from 8:18PM ET on Wednesday Jul 24, 2024 by Dow Jones
8:18PM ET on Wednesday Jul 24, 2024 by Dow Jones
Jul 23, 2024
ARS Pharmaceuticals Inc Investigated By The Schall Law Firm And Impacted Investors Urged To Engage In Dialogue, from 3:34PM ET on Tuesday Jul 23, 2024 by Dow Jones
3:34PM ET on Tuesday Jul 23, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ARS Pharmaceuticals Inc | 1.1B | -21.1x | --- |
Tyra Biosciences Inc | 1.1B | -11.9x | --- |
Viridian Therapeutics Inc | 1.0B | -3.7x | --- |
Cullinan Therapeutics Inc | 1.1B | -6.4x | --- |
Pharvaris NV | 938.6M | -6.8x | --- |
Enliven Therapeutics Inc | 1.2B | -14.2x | --- |
Company Information
ARS Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing neffy, for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, administered and nasal spray. Type I allergic reactions are potentially life-threatening hypersensitivity reactions that can occur within minutes of exposure to an allergen and need to be treated immediately to relieve symptoms and prevent further progression.
Contact Information
- Headquarters
- 11682 El Camino Real, Suite 120SAN DIEGO, CA, United States 92130
- Phone
- 858-771-9307
- Fax
- 845-818-3588
Executives
- Chairman of the Board
- Pratik Shah
- President, Chief Executive Officer, Director
- Richard Lowenthal
- Chief Financial Officer
- Kathleen Scott
- Chief Operating Officer
- Brian Dorsey
- Chief Business Officer
- Justin Chakma
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.1B |
|---|---|
Revenue (TTM) | $10.0K |
Shares Outstanding | 96.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.79 |
EPS | $-0.52 |
Book Value | $2.39 |
P/E Ratio | -21.1x |
Price/Sales (TTM) | 108,425.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -619,990.00% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
